Commerce Bank’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,137
Closed -$222K 1192
2025
Q1
$222K Buy
+3,137
New +$222K ﹤0.01% 1109
2024
Q4
Sell
-4,707
Closed -$331K 1183
2024
Q3
$331K Sell
4,707
-3,949
-46% -$278K ﹤0.01% 1028
2024
Q2
$713K Sell
8,656
-34,131
-80% -$2.81M ﹤0.01% 729
2024
Q1
$3.74M Buy
42,787
+6,218
+17% +$543K 0.02% 380
2023
Q4
$3.53M Sell
36,569
-3,050
-8% -$294K 0.03% 371
2023
Q3
$3.51M Sell
39,619
-139
-0.3% -$12.3K 0.03% 346
2023
Q2
$3.45M Buy
39,758
+34,559
+665% +$3M 0.03% 360
2023
Q1
$506K Buy
5,199
+627
+14% +$61K ﹤0.01% 802
2022
Q4
$473K Sell
4,572
-41
-0.9% -$4.24K ﹤0.01% 819
2022
Q3
$391K Buy
4,613
+79
+2% +$6.7K ﹤0.01% 861
2022
Q2
$376K Sell
4,534
-885
-16% -$73.4K ﹤0.01% 872
2022
Q1
$418K Buy
5,419
+198
+4% +$15.3K ﹤0.01% 887
2021
Q4
$461K Buy
5,221
+685
+15% +$60.5K ﹤0.01% 879
2021
Q3
$351K Sell
4,536
-2,624
-37% -$203K ﹤0.01% 958
2021
Q2
$597K Sell
7,160
-348
-5% -$29K ﹤0.01% 769
2021
Q1
$567K Buy
7,508
+515
+7% +$38.9K ﹤0.01% 764
2020
Q4
$613K Buy
6,993
+613
+10% +$53.7K 0.01% 703
2020
Q3
$485K Buy
6,380
+1,284
+25% +$97.6K ﹤0.01% 695
2020
Q2
$629K Buy
5,096
+1,155
+29% +$143K 0.01% 603
2020
Q1
$333K Buy
3,941
+439
+13% +$37.1K ﹤0.01% 720
2019
Q4
$296K Sell
3,502
-39,993
-92% -$3.38M ﹤0.01% 830
2019
Q3
$2.93M Buy
43,495
+36,064
+485% +$2.43M 0.03% 339
2019
Q2
$637K Buy
7,431
+388
+6% +$33.3K 0.01% 539
2019
Q1
$626K Sell
7,043
-134
-2% -$11.9K 0.01% 507
2018
Q4
$611K Buy
7,177
+3,574
+99% +$304K 0.01% 480
2018
Q3
$349K Buy
3,603
+417
+13% +$40.4K ﹤0.01% 695
2018
Q2
$300K Buy
+3,186
New +$300K ﹤0.01% 722
2018
Q1
Sell
-2,907
Closed -$259K 842
2017
Q4
$259K Buy
2,907
+662
+29% +$59K ﹤0.01% 754
2017
Q3
$209K Buy
+2,245
New +$209K ﹤0.01% 789